Ablation of GLRX in KRASG12D induced lung cancer elevates tumorigenesis and is associated with enhanced protein s-glutathionylation

被引：0
|
作者：
Janssen-Heininger, Yvonne [1 ]
Kinsey, Matt [1 ]
Chia, Shi Biao [1 ]
Peng, Zhihua [1 ]
Lahue, Karolyn [1 ]
van der Velden, Jos [1 ]
机构：
[1] Univ Vermont, Burlington, VT 05405 USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2018年 / 128卷
关键词：
D O I：
10.1016/j.freeradbiomed.2018.10.165
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
161
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 47 条
  • [1] Gstp1-Catalyzed S-Glutathionylation In Krasg12d-Induced Lung Tumorigenesis
    Van der Velden, J. L.
    Kinsey, C. M.
    Nolin, J. D.
    Abdalla, S. T.
    Lahue, K.
    Janssen-Heininger, Y. M. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] Pulmonary Inflammation And Cancer Cachexia In Krasg12d Induced Lung Adenocarcinoma
    Van der Velden, J. L.
    Langen, R.
    Kelders, M. C.
    Lahue, K. G.
    Janssen-Heininger, Y. M. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] The Role Of Eosinophils In Krasg12d Induced Lung Tumor Initiation And Progression
    Li, F.
    Du, X.
    Zhang, C.
    Li, W.
    Chen, Z.
    Ying, S.
    Shen, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [4] FOXM1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D
    Wang, I-Ching
    Ustiyan, Vladimir
    Zhang, Yufang
    Cai, Yuqi
    Kalin, Tanya V.
    Kalinichenko, Vladimir V.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [5] Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D
    Wang, I-C
    Ustiyan, V.
    Zhang, Y.
    Cai, Y.
    Kalin, T. V.
    Kalinichenko, V. V.
    ONCOGENE, 2014, 33 (46) : 5391 - 5396
  • [6] Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D
    I-C Wang
    V Ustiyan
    Y Zhang
    Y Cai
    T V Kalin
    V V Kalinichenko
    Oncogene, 2014, 33 : 5391 - 5396
  • [7] On the impact of KRASG12D subtype non-small cell lung cancer
    Lopez, Sandra
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [8] Targeting the "Undruggable" Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (04): : 365 - 366
  • [9] Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRASG12D protein to cancer-associated fibroblasts
    Liu, Xinyuan
    Yang, Jiaqi
    Huang, Sicong
    Hong, Yifan
    Zhu, Yupeng
    Wang, Jianing
    Wang, Yi
    Liang, Tingbo
    Bai, Xueli
    MOLECULAR THERAPY, 2025, 33 (03) : 1134 - 1153
  • [10] The impact of MRTX1133 on anti-tumor immunity in lung cancer with KRASG12D mutation
    Shono, Kunihiro
    Watanabe, Satoshi
    Masuda, Takaaki
    Suzuki, Ryo
    Wakabayashi, Tomoya
    Sekiya, Tomoki
    Tanaka, Susumu
    Ohtsubo, Aya
    Tanaka, Tomohiro
    Nozaki, Koichiro
    Kondo, Rie
    Saida, Yu
    Hokari, Satoshi
    Yanagimura, Naohiro
    Arita, Masashi
    Ohashi, Riuko
    Shima, Kenjiro
    Kimura, Yosuke
    Aoki, Nobumasa
    Ohshima, Yasuyoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER RESEARCH, 2024, 84 (06)
12345